Ashwani Sharma

656 total citations
19 papers, 372 citations indexed

About

Ashwani Sharma is a scholar working on Molecular Biology, Pharmaceutical Science and Oncology. According to data from OpenAlex, Ashwani Sharma has authored 19 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pharmaceutical Science and 3 papers in Oncology. Recurrent topics in Ashwani Sharma's work include Medicinal Plants and Neuroprotection (3 papers), Advanced Drug Delivery Systems (3 papers) and Computational Drug Discovery Methods (2 papers). Ashwani Sharma is often cited by papers focused on Medicinal Plants and Neuroprotection (3 papers), Advanced Drug Delivery Systems (3 papers) and Computational Drug Discovery Methods (2 papers). Ashwani Sharma collaborates with scholars based in India, Bangladesh and Yemen. Ashwani Sharma's co-authors include Tarun Virmani, Girish Kumar, Kamla Pathak, Abdulsalam Alhalmi, Devender Pathak, Abdulmalik Saleh Alfawaz Altamimi, Md Sayeed Akhtar, Obaid Afzal, Avijit Mazumder and A. Sharma and has published in prestigious journals such as BioMed Research International, Polymers and Current Pharmaceutical Design.

In The Last Decade

Ashwani Sharma

17 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashwani Sharma India 12 109 64 57 50 44 19 372
Girish Kumar India 15 119 1.1× 83 1.3× 82 1.4× 95 1.9× 57 1.3× 47 542
Rinku Baishya India 12 164 1.5× 102 1.6× 42 0.7× 50 1.0× 53 1.2× 31 412
Pankti C. Balar India 15 121 1.1× 54 0.8× 46 0.8× 22 0.4× 65 1.5× 29 428
Saima Iftikhar Pakistan 7 106 1.0× 102 1.6× 68 1.2× 40 0.8× 82 1.9× 16 427
Laboni Mondal India 11 161 1.5× 104 1.6× 25 0.4× 61 1.2× 57 1.3× 13 403
Dongchun Liu China 14 177 1.6× 76 1.2× 48 0.8× 80 1.6× 88 2.0× 34 482
Muddasarul Hoda India 11 115 1.1× 51 0.8× 35 0.6× 20 0.4× 61 1.4× 29 396
Yinghan Chan Malaysia 15 195 1.8× 63 1.0× 52 0.9× 39 0.8× 72 1.6× 21 540
Monica Gulati India 13 133 1.2× 36 0.6× 19 0.3× 39 0.8× 37 0.8× 36 496
Yiping Guo China 12 141 1.3× 75 1.2× 19 0.3× 23 0.5× 66 1.5× 27 390

Countries citing papers authored by Ashwani Sharma

Since Specialization
Citations

This map shows the geographic impact of Ashwani Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwani Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwani Sharma more than expected).

Fields of papers citing papers by Ashwani Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwani Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwani Sharma. The network helps show where Ashwani Sharma may publish in the future.

Co-authorship network of co-authors of Ashwani Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwani Sharma. A scholar is included among the top collaborators of Ashwani Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwani Sharma. Ashwani Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sharma, Ashwani, et al.. (2025). Epigenetics Modulators as Therapeutics for Neurological Disorders. Current Pharmaceutical Design. 31(19). 1499–1520. 1 indexed citations
2.
Sharma, Ashwani, Tarun Virmani, Girish Kumar, et al.. (2025). Ethnopharmacological Profile, Phytochemistry and Therapeutic Potential of Aegle marmelos L. for the Treatment of Neurological Disorders. Journal of Nutrition and Metabolism. 2025(1). 2275526–2275526.
3.
Sharma, Ashwani, Tarun Virmani, Girish Kumar, et al.. (2024). Mitochondrial signaling pathways and their role in cancer drug resistance. Cellular Signalling. 122. 111329–111329. 14 indexed citations
4.
5.
Singh, Kuldeep, et al.. (2024). Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders. Current Pharmaceutical Biotechnology. 26(10). 1582–1595. 1 indexed citations
6.
Virmani, Tarun, et al.. (2024). Unveiling the Link Between Breast Cancer Treatment and Osteoporosis: Implications for Anticancer Therapy and Bone Health. BioMed Research International. 2024(1). 5594542–5594542.
7.
Kumar, Girish, Tarun Virmani, Ashwani Sharma, et al.. (2024). Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin. Therapeutic Delivery. 15(9). 717–735. 2 indexed citations
8.
Kumar, Girish, Tarun Virmani, Shashi Kiran Misra, Ashwani Sharma, & Kamla Pathak. (2024). Exploration of chitosan and its modified derivatives as vaccine adjuvant: A review. Carbohydrate Polymer Technologies and Applications. 8. 100537–100537. 12 indexed citations
9.
Mazumder, Avijit, et al.. (2023). A Comprehensive Review of the Pharmacological Importance of Dietary Flavonoids as Hepatoprotective Agents. Evidence-based Complementary and Alternative Medicine. 2023(1). 4139117–4139117. 25 indexed citations
10.
Sharma, Ashwani, Devender Pathak, Tarun Virmani, et al.. (2023). Attenuation of Strychnine-Induced Epilepsy Employing Amaranthus viridis L. Leaves Extract in Experimental Rats. Behavioural Neurology. 2023. 1–10. 9 indexed citations
11.
Kumar, Girish, Tarun Virmani, Ashwani Sharma, & Kamla Pathak. (2023). Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers. Pharmaceutics. 15(3). 889–889. 45 indexed citations
12.
Singh, Kuldeep, Bharat Bhushan, Satish Kumar Sharma, et al.. (2023). Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review. Behavioural Neurology. 2023. 1–17. 34 indexed citations
13.
Kumar, Mahesh, Tarun Virmani, Girish Kumar, et al.. (2023). Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies. Pharmaceuticals. 16(10). 1360–1360. 28 indexed citations
14.
Garabadu, Debapriya, et al.. (2023). Understanding the Cross-Talk between the Ceramide Biosynthetic Pathway and Mitochondrial Function in Multiple Sclerosis and Demyelinating Disorders. Acta Neurologica Scandinavica. 2023. 1–17. 3 indexed citations
15.
Virmani, Tarun, Girish Kumar, Ashwani Sharma, et al.. (2023). Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates. Polymers. 15(13). 2928–2928. 57 indexed citations
16.
Sharma, Ashwani, et al.. (2022). Antidepressive‐Like Effect of Aegle marmelos Leaf Extract in Chronic Unpredictable Mild Stress‐Induced Depression‐Like Behaviour in Rats. BioMed Research International. 2022(1). 6479953–6479953. 14 indexed citations
17.
Sharma, Ashwani, et al.. (2022). Artificial Intelligence‐Based Data‐Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine. BioMed Research International. 2022(1). 7205241–7205241. 60 indexed citations
18.
Sharma, Ashwani, Tarun Virmani, A. Sharma, et al.. (2022). Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1845–1864. 19 indexed citations
19.
Virmani, Tarun, et al.. (2022). Nanocarrier-Based Approaches to Combat Chronic Obstructive Pulmonary Disease. Nanomedicine. 17(24). 1833–1854. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Girish Kumar Breakdown of academic impact, for papers by Rinku Baishya Breakdown of academic impact, for papers by Pankti C. Balar Breakdown of academic impact, for papers by Saima Iftikhar Breakdown of academic impact, for papers by Laboni Mondal Breakdown of academic impact, for papers by Dongchun Liu Breakdown of academic impact, for papers by Muddasarul Hoda Breakdown of academic impact, for papers by Yinghan Chan Breakdown of academic impact, for papers by Monica Gulati Breakdown of academic impact, for papers by Yiping Guo
Rankless by CCL
2026